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Annual coronary arteniograms have been obtained from nil
heart transplant recipients at Stanford University Medical
Center store 1969. Anglographic lesions in 81 transplant
patients exhibiting coronary vascular disease mire classified
into three categories- type A, discrete or tubular slenases ;
type B, diffuse concentric narrowing ; and type C, narrowed
irregular vessels with occluded branches. The 81 arlerio
.
grams showing transplant coronary vascular disease were
contrasted with 32 from noninosplant patients with coro-
nary artery disease analyzed in a similar fashion .
The nontransplantanglograms showed 178 lesions, all of
type A (discrete or tubular) morphology, 75% of which
were located in primary epicardial coronary vessels and
25% in secondary branch vessels. In the patients with
transplant coronary vascular disease, 349 (76%) of 461
lesions were type A : 57% In primary vessels, 42% in
secondary branches and 1.4% In tertiary branches . Of the
Four hundred heart transplant procedures and 30 heart and
lung transplant procedures were performed in 368 and 29
patients, respectively, at Stanford University Medical Cen-
ter from January 6, 1968 to December 31, 1985 . One year
survival rates for heart transplant recipients increased from
22% in 1%9 (1) to 83.4% in 1985 . Early mortality, which
generally results from acute rejection, acute donor heart
failure or infectious complications, has decreased substan .
tially . Later stage cernplications, particularly accelerated
coronary vascular disease, have become major causes of late
morbidity and mortality
(2-4)
.
Because lack of afferent
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112 type B and C lesions (diffuse narrowing, tapering and
obliteration), 25% were In primary vessels, 44% in second.
ary vessels and 31% In tertiary branches (p < 0 .05 for
patients with transplant coronary vascular disease versus
patients with nentransplant coronary artery disease)
. Total
vessel activation was found in proximal or middle vessel
segments In %% and distally in 4% of patients with
"ordinary" coronary artery disease versus 49% distally In
patients with transplant coronary disease (p < 0 .002), In
the presence of total vessel occlusion, collateral vessels
were
poor orabsent 1. 92% of transplant versus 7% of nonirans-
plant patients wish coronary disease (p < 0
.002).
Therefore, coronary artery disease In transplant patients
represents a mlature of typical atheromatms Wants and
unique trnspast-related progressive distal obliterative dis .
ease that occurs without collateral vessel development .
(J Ana Cod Cordite!
1988;12.334-40)
cardiac innervation makes transplant recipients unable to
experience angina pectoris, the first sign of transplant coro
.
nary disease can be the appearance of silent myocardial
infarction on the electrocardiogram, development of conges-
tive heart failure or ventricular arrhythmia leading to sudden
death. Because the disease can be clinically silent and can
progress rapidly in many cases, annual coronary arledograms
have been performed as a matter of policy in all heart
transplant patients at Stanford . A total of 634 of these
sequential coronary arteriograms were available for analysis .
The purposes of this study are 1) to evaluate the preva-
lence of accelerates coronary vascular disease in the cardiac
allograft, and 2) to study the characteristic angiographic
features of this process and delineate its differences from
"ordinary" (nontransplant) coronary angiographic lesions .
Methods
Study patients
. The patient data base for this study con-
sisted of 221 heart transplant patients (including 13 heart and
0735-1097!8&53.30
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lung transplant patients) and 32 nontransplant patients with
coronary artery disease diagnosed by standard clinical and
angiographic criteria .
The transplant recipients were classified into two groups:
The first group consisted of 132 patients (including 13 heart
and lung transplant recipients) who underwent heart trans-
plantation after 1979, survived at least 1 year and had annual
follow-up arteriography for I to 5 years (mean 2 .4) . The
second group consisted of 37 patients who had transplant
procedures before 1979, survived at least I year and had
annual coronary angiography for a mean of 5 .3 years during
which development of coronary vascular disease was docu-
mented . An additional 52 heart transplant patients operated
on before 1979 who survived at least 1 year without known
development of coronary disease were excluded because
many of their early arteriograms were not available for
comparison with later studies .
A third group consisted of 32 nontransplant patients with
clinically stable, medically treated coronary artery disease
who were participating in a separate research protocol and
who had both baseline arteriograms and repeat studies
performed 5 years later .
Cardiac catheterization. All patients were evaluated with
left and right heart catheterization and selective coronary
arteriography using the percutaneous femoral approach.
Left ventricular cineangiography was performed in alt pa-
tients . Cardiac output was determined by the Fick method.
The procedures for cardiac catheterization were explained to
all patients and informed consent was obtained under Stan-
ford Institutional Review Board guidelines .
Coraoary arterlogiaphy. On the basis of a pilot project
reviewing serial arteriograms in 15 transplant hearts with
coronary disease, a list of descriptors for various coronary
morphologic abnormalities and collateral vessel qualities
was developed. These descriptors were used in interpreting
the arteriograms of both transplant and nontransplant pa-
tients with coronary diseases . The angiographic findings
were reviewed by two angiographers independently, and a
consensus on interpretation was reached . All arteriographic
interpretations were based on side by side comparisons of
serial films .
The following anatomic abnormalities were coded (Fig.
1):Type A, discrete stenoses, tubular stenoses and multiple
stenoses in the proximal, middle or distal segment branches ;
type B, diffuse concentric narrowing with onset in mid to
distal artery; type B I , proximal vessel maintaining normal
diameter with abrupt onset of distal concentric narrowing
and obliteration; type B2, gradual transition from normal
proximal vessel with tapering concentric narrowing gradu-
ally
increasing in severity distally ; and type C, diseased
vessels, diffusely irregular, that have lost small branches ;
they do not taper normally but exhibit terminations that are
often nontapered, squared off and end abruptly.
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TYPE52LESI01
TYPE a LESIN
Figure l. Anatomic abnormalities in transplant coronary vascular
disease. Type A
lesion : discrete, tubular or multiple stenoses . Type
B I lesion: abrupt onset with distal diffuse concentric narrowing and
obliterated vessels . Type
B r
lesion
: gradual, concentric tapering
with distal portion having sonic residual lumen
. Type C lesion
:
narrowed irregular distal branches with termination that are often
nontapered and squared off, ending abruptly .
Definition of arterial vessels . These anatomic abnormali-
ties were identified as being in primary, secondary or tertiary
vessels.
Primary vessels. These are the large epicardial vessels,
including the left main, left anterior descending, left circum-
flex and right coronary arteries.
Secondary vessels. These are the major branch vessels of
the primary epicardial coronary vessels . The major diagonal,
marginal. posterior descending and posterolateral branches
constitute the secondary branches .
Tertiary vessels. These are angiographically visible small
branches of both primary and secondary vessels . They are
larger in diameter than the fine arteriolar or capillary net-
work, but are short in length and subtend relatively small
areas of myocardium.
Both primary and secondary vessels are of sufficient
length to divide into proximal, middle and distal segments .
Segmentation for primary vessels was based on nomencla-
ture used in the Coronary Artery Surgery Study (5) ; that for
secondary vessels was based on equal subdivisions.
Criteria for collateral vend qualIty . Good: The collateral
channels are discrete and visible . Collateralized vessels are
visualized so that walls and lesions can be identified. Fair:
The proximal or distal segments of collateralized vessels are
filled, but not enough to visual anatomic detail . Poor : The
collateralized vessels are faintly filled . None: There is no
visualization of the main trunk of occluded vessel other than
scattered tiny disconnected faint twigs .
Statistical Andynlw All data are presented as mean ± I
SD . Comparisons among groups were analyzed with the
two-sample Student's t test for differences in proportion and
means, respectively . The chi-square test was used to assess
intergroup differences in distribution of lesions, quality of
collateral supply and incidence of transplant coronary dis-
ease . A difference of p < 0 .05 was considered statistically
significant .
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Table 1,
Incidence of Coronary Vascular Disease in 221 Heart
Transplant Recipients
TxCVD
m
transplant coronary vascular disease .
Results
Prevalence of transplant coronary vascular disease (Table
1). Forty-four (33%) of 132 heart transplant patients oper-
ated on after 1979 showed angiographic evidence of trans-
plant coronary disease. In patients operated on before 1979,
37 (41 .5%) of 89 had documented coronary artery lesions .
The prevalence of coronary disease was higher in the avail-
able patients in the pre-1979 group than in patients in the
post-1979 group (p > 0.05) ; this difference is at least in ;part
explained by the longer follow-up period for the early group .
Arteriographic findings of transplant coronary vascular
disease. For morphologic analysis, the 37 pre-1979 trans-
plant patients with angiographic coronary vascular disease
were included with the 44 post-1979 transplant patients who
also exhibited coronary disease . To demonstrate time of
initial detection of coronary disease in these 81 transplant
recipients, cumulative occurrence rates for transplant coro-
nary disease in relation to time after surgery are shown in
Figure 2
. Definite angiographic coronary disease was de-
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Figure 2. Timing of initial detection of cardiac
transplant-accelerated
coronary vascular disease (TxCVD) in 81 transplant patients .
tected in 34 .5% of these 81 patients in the first year, 59% the
second year and 91% 5 years after transplantation . Examples
of these typical morphologic features and their progression
are shown in Figures 3 through 7 .
Analysis of the distribution of lesions revealed a signifi-
cant difference between transplant and nontransplant pa-
tients (Table 2). In patients with transplant coronary vascu-
lar disease, most of the concentric and distal obliterative
lesions of types B„ Bi and C appeared in the secondary
vessels (type B l , 27 [24%l ; type B 2 , 10 [9%] ; type C, 12
111%]) and tertiary vessels (type B„ 1 [0 .8%] ; type B„ 2
12%1 ; type C, 32 [28.5%]) . In contrast, no type B„ B2
Of
C
lesions were seen in the nontransplant coronary artery
disease group. Sixty patients (74%) with transplant coronary
disease showed some type A lesions in primary branch
vessels . In comparison, type A lesions appeared in primary
branch vessels of all nontransplant patients with coronary
artery disease . Table 3 summarizes the distribution of the
concentric tapering and obliterative type II I
, B2 and C
lesions that have a clear association with transplant coronary
disease.
Figure 3. Right anterior oblique view
of left coronary artery injection show-
ing essentially normal left coronary
anatomy I year after cardiac transplan-
tation (left) . Five years after transplan-
tation (right), the arleriogram shows a
totally occluded left circumflex artery
and a discrete lesion in the obtuse
marginal artery (type A lesions), a type
B, lesion in the diagonal branch and a
type B2 lesion in the obtuse marginal
branch.
Year of
Transplant
Procedure
No . of
Patients
Angiagraphic
Follow-up
(mean years) Incidence
196810 1978
TxCVD 37 37 of 89
No TxCVD 52
Total 89 5 .3
(41 .5%)
1979 to 1984
TxCVD 44 41or132
No TxCVD 88
Taw
132 2 .4 (33%)
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Figure 4. Left coronary artery aneriogram shows es-
sentially normal arstomy I year after cardiac trans-
plantation (left)
. Four years after transplantation
(right), the arteriogrom shows a B, lesion in the distal
left
anterior descending coronary artery and both B,
and C lesions in the distal branches of the obtuse
marginal artery (arrows)
.
Comparison of the site of total occlusion of vessels and
tire quality of collateral vessel formation also revealed
striking differences between the two groups (Table
4). In
transplant patients, 16 (43%) of 37 vessels were occluded
proximally and 18 (49%) of 37 vessels were occluded in their
distal segments . In the nontransplant patients with coronary
artery disease, 21 (72%) of 29 vessels had occluded in the
proximal segment and only 1 (3.5%) of 29 vessels had
occluded distally .
Collateral vessel formation was very poor !it transplant
patients (Table 5) . Collateral vessels to occluded vessels
could not be seen at all in 29 (78%) of the 37 arteries, and S
(14%) of the 37 occluded vessels had only faintly filled
collateralized vessels . In contrast, in the nontransplant
group with coronary artery disease, 22 (76%) of 29 occluded
vessels had good collateral vessels and 5 (17%) of 29
occluded vessels had fair collateral vessels . In no instance
were collateral vessels absent
.
Discussion
Prevalence of coronary vascular disease . A very diffuse
and often rapidly progressive type of occlusive coronary
vascular disease has been found to affect a substantial
number of cardiac allograft recipients in the late postopera-
tive period. As survival after cardiac transplantation im-
proves because of increasingly successful management of
Figure 5 . Left coronary artery arteriogram shows
essentially normal anatomy I year after cardiac trans-
plantation (left). Three years after transplantation
(right), the arteriogram shows type B, lesions in the
left circumflex and marginal coronary arteries and a
type B, lesion in the distal anterior descending coro-
nary artery.
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allograft rejection and infectious complications, accelerated
coronary vascular disease or allograf atherosckrosis may
constitute the major limitation to long-term survival forheart
transplant recipients (6) .
The incidence of angiogenphic coronary vascular disease
in heart transplant recipients was first reported by the
Stanford group in 1981 (2) to be approximately 40% (21 of 85
patients) at 5 years after transplantation, More recent data
from our group (7) suggest that this incidence has not
changed since the introduction of cyclosporine-based immu-
nosuppression in 1980. The more exhaustive review reported
here confirms the previously described high incidence of the
disease . It is worthwhile to note here that these prevalence
figures denote only the angiographic documentation of some
disease but not its severity or the existence of clinical
sequelae . Many of these patients have apparently mild
disease with as yet no detectable clinical sequelae .
Arteriographic findings . Analysis of coronary arterio-
grams of affected cardiac allografts presented here reveals
unique morphologic features of this disease consisting of
diffuse concentric narrowing, prominent in middle to distal
vessels, with distal vessel obliteration
. The vessels narrow
distally in one of three ways : 1) gradual transition from
normal proximal vessel with smooth concentric tapering, the
distal vessel having some residual lumen (type B 2); 2) abrupt
narrowing with concentrically narrowed and obliterated dis-
tat vessel (termed "pruning"), with only faintly visualized
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Figure 6. The left coronary artery arteriogran shows essentially
normal anatomy I year after cardiac transplantation (top). Pour
years after transplantation (bottom), the arteriogram shows type B,
lesions in the obtuse marginal branch .
channels remaining (type 8,) ; and 3) narrowed irregular
distal branches with loss of small branches (type C)
. These
type C vessels often contain some ectahc areas following
areas of narrowing ; their terminations are often nontapered
and squared off and end abruptly. In terminal branch coro-
nary vessel segments, type C lesions predominate, whereas
in conduit coronary segments, type A lesions predominate .
There is a striking lack of development of collateral blood
supply to affected vessels, with supply graded as poor or
absent in 92% of the totally occluded vessels in 20 transplant
patients with coronary diseases
.
These unique
morphologic findings in arteriograms of
transplant coronary disease
differ greatly from arteriogrt-
No. of Lesions
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Table 2 . Comparison of Different Types of Lesions in Primary,
Secondary and Tertiary Brooch Vessels of Coronary Arteries in
SI Transplant Patients Versus 32 Nontransplant Patients With
Coronary Disease
Lesion type
: A = discrete smnada,
B, =
concentric-sharp taper, B, _
-centric-gradual taper, C = distal obliteration. CAD = nontrenrplent
coromry, artery disease ; N8 = not significant
; TxCVD = transplant coronary
vascular disease.
phic features in typical nontransplant patients with coronary
artery disease
. However, a number of typical proximal
discrete stenoses similar to those in nontransplant patients
were also noted . Thus, angiographic findings in transplant
coronary vascular disease are a mixture of both typical
atherosclerotic lesions and unusual, presumably transplan-
tation-related, progressive diffuse distal obliterative disease
without collateral vessel development .
Figure 7 . The left coronary artery arteriogram shows
essentially normal anatomy I year after cardiac trans-
plantation (left). Five years after transplantation
(nelddk), the arteriogram shows smooth concentric
narrowing in the mid to distal left anterior descending
coronary, artery and a tubular stenosis after takeoff of
the second diagonal branch
. Nine years after turns.
plantation (right), the arteriogram shows a diffusely
diseased left anterior descending coronary artery.
Lesion
Type
TACVD CAD
(91 patients) (32 patients)
P
Value
Primary Vessels
A 198 133 <0 .001
B, 17 0 <0 .05
8 2 It 0 N8
C 0 0 NS
Secondary Vessels
A 146 44 NS
B, 27 0 <0.05
B, 10 0 NS
C 12 0 NS
Tertiary Vessels
A 5 1 N8
B, I 0 NS
B2 2 0 N8
C 32 0 <0.05
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Table 3. Comparison of Type A Lesions and Other Types of
Lesions in 81 Transplant Patients Versus 32 Nontransplant
Patients With Coronary Disease
Abbreviations as in Table 2 .
Morphologic changes . The angiographic features of trans-
plant coronary disease described here can be related to
histopathologic changes described in explanted allografts or
allografts examined at autopsy (8-10) . The histopathologic
changes of atherosclerosis in human cardiac allograft recip-
ients were first described in autopsy findings from 12 pa-
tients. These changes consisted
of a circumferential and
longitudinal increase in intimalfibrous tissue and myointimal
cells limited to coronary arteries with muscular media and
not present in arterioles and veins . The thickness of the
intima was roughly proportional to the age of the graft, with
some thickening developing as early as 9 days ; thickening
was present in six of seven allografts from patients surviving
>1 month
. Of note, purely proliferative intimal lesions were
seen in grafts studied early after implantation, and large
numbers of lipophages and lipid droplets appeared in grafts
studied later
(9,1). Atherosclerotic lesions in major coro-
nary arteries of patients who die from transplant coronary
vascular disease are histopathologically similar in composi-
tion to those occurring in nontransplant coronary artery
disease (8) but differ in their diffuse distribution, correlating
well with the arteriographic features of transplant coronary
disease we have described.
Follow-up and therapy . Because of the longitudinal and
concentric distribution of transplant coronary vascular dis-
ease, it is important to compare serial angiogroms to detect
a general decrease in caliber of vessels, "dropout" of
Table 4. Comparison of Site of Occlusive Coronary Disease in 20
Transplant Patients Versus 16 Nontransplant Patients in Serial
Angiographic Studies
Abbreviations as in Table 2 .
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Table 5. Comparison of the Quality of Collateral Supply in Serial
Angiographic Studies of 20 Transplant Patiens Versus 16
Nontransplant Patients With Coronary Disease
No. of
Quality of Conateral supply
No. of Occluded
P
Patents Vessels Goad Fair Poor None Value
TSCVD 20 37 1 2 5 29 0.0002
(3%) (5%) (14%1 (78%)
CAD 16 29 22 5 2
0
(76%) (17%) (7%)
(0%)
Abbreviations as in Table 2.
branches or distal "pruning" of vessels . Precise quantitation
of progressive concentric narrowing may be done by serial
quantitative arteriography, and prospective studies with this
technique are underway in our institution. The Stanford
group initially decided to perform angiograms in this patient
group at I year intervals . Because of the abrupt occurrence
of severe coronary disease within a single year in a number
of these patients, this interval has never been increased. The
diffuse distribution and rapid progression of transplant cor-
onary disease makes these patients poor candidates for
conventional therapy with angioplasty or coronary artery
bypass graft surgory. Filective retransplantation, currently
the only recognized treatment for severe stages of transplant
coronary disease, is offered to patients believed to be at high
risk of death from this disease .
Pathogenesis of transplant coronary vascular disease. De-
spite many investigations (12,13), the pathogenesis of trans-
plant coronary disease remains undetermined, although
some type of vascular immunologic injury is presumed by
most to be involved . The lesions of experimental cardiac
allograft atherosclerosis were first described at the micro-
scopic level (14) in material from canine cardiac allografts;
that study also noted a time-related occurrence of coronary
intimal thickening, not correlated with acute allograft rejec-
tion, which was present in almost all the large coronary
arteries in dogs surviving >1 year . Other investigators have
demonstrated the induction of occlusive allograf coronary
vascular disease in rat (13,15) and rabbit (16) models . Relat-
ing these observations to the histopatholrgic change in
human allograft atherosclerosis has led to the assumption
that initial proliferative intimal lesions eventually become
infiltrated with lipid and, subsequently, fibrous scoring ad-
ditionally leads to the nonspecific appearance of ordinary
atherosclerotic disease. Accelerated vascular disease has
been observed in other organ grafts (17,18). Histopathologic
changes described in the arteries of renal grafts include
fibroproliferative lesions in the intima, necrosis of the media
and degeneration of smooth muscle cells . The arterial intima
is thickened by myofibroblast proliferation, which can lead
to severe narrowing or even occlusion of the arterial lumen
and can result in renal infarctions (19,20). These arterial
Group
No. of
Patients
Total
Lesions
P
Value
Type A lesion
T5CVD 81 349 NS
CAD 32 178
Type B, + 5, + C
twin,,,
TsCVD
81 112 <0 .001
CAD
32
0
Group
No . of
Patients
No . of
Occluded
Vessels
Site of Vessel Occlusion
p
ValueProximal Middle Distal
T5CVD 20 37 16 3 18
(43%) (8%) (48%) 00002
CAD 16 29 21 7 1
(72%) (24%) (3.5%)
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changes are similar to the intimal proliferative lesions noted
in transplant patients with coronary disease (8).
The extent to which immunologic injury or steroid use
contributes to transplant coronary vascular disease is un-
certain . Coronary atherosclerosis and myocardial infarction
associated with systemic Inputs erythematosus in young
adults have been reported (21,22). Thirty-six patients with
systemic ]opus erythematosus who had received long-term
corticosteroid treatment and
20
patients who did not were
compared in one study. Twenty (56%) of the 36 cortico-
steroid-treated patients showed intramural coronary artery
narrowing . These vessels were narrowed by fibrous intimal
proliferation and sometimes the endothelial cells were de-
generated . The walls of these vessels were occasionally
necrotic. Extramural coronary artery narrowing by >50%
was noted in 9 (25%) of 36 patients
. Atherosclerotic plaques
blocked these vessels (23).
High levels of serum lipids are known to correlate with
increased incidence of ordinary coronary artery disease and
could be contributing factors in the pathogenesis of trans-
plant coronary vascular disease. Elevated levels of serum
triglyceride have been noted in patients with transplant
coronary disease (1,6,24), but elevated cholesterol levels
have not, and the incidence of coronary disease has shown
surprisingly little correlation with lipid levels in transplant
recipients.
It seems likely that immunologic injury is the primary
mechanism of this disease, although proof or correlation
with incidence of rejection episodes is lacking. Immunotog-
ically induced injury to the coronary artery intima theoreti-
cally could lead to platelet aggregation and intimal thicken-
ing and eventually to obliterative arterial disease . Thus the
development of new immunosuppressive modalities that
more effectively and selectively control the immune re-
sponse may be necessary to dec ;zase the incidence of this
disease.
Conclusions, 1) Coronary vascular disease is a frequent
late postoperative complication in heart transplant recipi-
ents. 2) Cardiac transplant accelerated coronary vascular
disease is a mixture of
typical proximal atherosclerotic
lesions and unusual diffuse obliterative disease, character-
ized by concentric and longitudinal narrowing with distal
pruning, vessel obliteration and absence of collateral ves-
sels . 3)
Accurate detection of progressive concentric nar-
rowing and distal vessel obliteration necessitates side by side
comparison of serial angiograms .
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